Insider Trading: Isis Pharmaceuticals Inc (ISIS.O)

ISIS.O on Nasdaq

20.81USD
21 May 2013
Price Change (% chg)

$0.35 (+1.71%)
Prev Close
$20.66
Open
$20.45
Day's High
$20.85
Day's Low
$20.28
Volume
906,524
Avg. Vol
1,624,301
52-wk High
$23.03
52-wk Low
$7.55

Search Stocks
BERTHELSEN SPENCER R Options Exercised: 0
Trade Date: Sunday, 24 Jun 2012 Price: 8.15
Title: Director Shares Held: 29,370
Type Traded: Direct Net Change in Shares This Filing: 0
» More Insider Trading

Institutional Holders

% Shares Owned: 78.34%
# of Holders: 215
Total Shares Held: 87,501,733
3 Mo. Net Change: 6,526,826
# New Positions: 51
# Closed Positions: 19
# Increased Positions: 101
# Reduced Positions: 85
# Net Buyers: 16

Officers & Directors

Name Age Since Current Position

Stanley Crooke

 67 1991 Chairman of the Board, President, Chief Executive Officer

Elizabeth Hougen

 51 2013 Chief Financial Officer, Senior Vice President - Finance

B. Lynne Parshall

 58 2013 Chief Operating Officer, Corporate Secretary, Director

Patrick O'Neil

 39 2013 Senior Vice President - Legal, General Counsel

C. Frank Bennett

 56 2006 Senior Vice President - Antisense Research

Richard Geary

 55 2008 Senior Vice President - Development

Brett Monia

 51 2012 Senior Vice President - Drug Discovery and Corporate Development

Spencer Berthelsen

 60 2002 Independent Director

Joseph Klein

 51 2005 Independent Director

Frederick Muto

 2001 Independent Director

Joseph Wender

 67 1994 Independent Director

Wade Walke

 Executive Director - Corporate Communications
Search Stocks